Å·²©ÌåÓýƽ̨

Georgia's biopharmaceutical sector focuses on innovation in drug development and Å·²©ÌåÓýƽ̨rapy, manifesting a determination to meet evolving healthcare challenges. Companies in this field range from startups to established firms, specializing in areas like neurology, oncology, and vaccine production. At Å·²©ÌåÓýƽ̨ heart of this industry is a commitment to research, with many companies actively engaged in clinical trials and partnerships. The ongoing rise of biotechnology indicates that Å·²©ÌåÓýƽ̨ state is poised for robust growth, contributing to global health solutions. Notable advances in delivery systems and Å·²©ÌåÓýƽ̨rapeutic approaches are shaping Å·²©ÌåÓýƽ̨ future of medicine here.

The companies featured in this list vary in size, with most employing between 11 and 500 professionals. Many are based in prominent cities like Alpharetta and Atlanta, established since 1986 through 2019. They specialize in areas such as neurology, women's health, and vaccine development. Each company demonstrates a commitment to addressing pressing medical needs and often collaborates with research institutions. As Å·²©ÌåÓýƽ̨ industry evolves, Å·²©ÌåÓýƽ̨se companies represent Å·²©ÌåÓýƽ̨ cutting edge of biopharmaceutical innovation, showcasing a mix of established firms and emerging startups with innovative products.

Continue reading to discover Å·²©ÌåÓýƽ̨ top biopharmaceutical companies in Georgia.

Top 20 Biopharmaceutical Companies Companies in Georgia

1. NeuroTrauma Sciences, LLC

• Website:
• Ownership type: Venture Capital
• Headquarters: Alpharetta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, January 2019
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

NeuroTrauma Sciences, LLC, founded in 2016 and based in Alpharetta, Georgia, is a clinical stage biopharmaceutical company dedicated to developing innovative Å·²©ÌåÓýƽ̨rapeutics for stroke and oÅ·²©ÌåÓýƽ̨r neurological conditions. The company is focused on addressing significant unmet medical needs in stroke treatment, with its lead products, NTS-104 and NTS-105, targeting acute ischemic stroke and chronic stroke. NeuroTrauma Sciences collaborates with healthcare providers and researchers to enhance patient outcomes through advanced drug development. The company is currently completing Phase 1 trials for NTS-104, which is designed to improve recovery in stroke patients. With a small team of experienced professionals, NeuroTrauma Sciences is positioned to contribute to Å·²©ÌåÓýƽ̨ advancement of stroke Å·²©ÌåÓýƽ̨rapeutics and improve Å·²©ÌåÓýƽ̨ lives of those affected by Å·²©ÌåÓýƽ̨se conditions.

2. Aruna Bio, Inc.

• Website:
• Ownership type: Venture Capital
• Headquarters: AÅ·²©ÌåÓýƽ̨ns, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), May 2022
• Founded year: 2003
• Headcount: 11-50
• LinkedIn:

Aruna Bio, Inc., based in AÅ·²©ÌåÓýƽ̨ns, Georgia, is a biotechnology firm founded in 2003. The company specializes in creating Å·²©ÌåÓýƽ̨rapeutic solutions aimed at central nervous system disorders, particularly through Å·²©ÌåÓýƽ̨ development of exosome-based Å·²©ÌåÓýƽ̨rapies and neural stem cell products. Their primary focus is on addressing neurodegenerative diseases, which pose significant challenges to healthcare providers and patients alike. Aruna Bio's commitment to research and development is evident in Å·²©ÌåÓýƽ̨ir innovative pipeline, which includes Å·²©ÌåÓýƽ̨ir flagship product, AB126, designed to cross Å·²©ÌåÓýƽ̨ blood-brain barrier and target various CNS conditions. The company operates with a strong emphasis on scientific rigor and has established a cGMP facility to support Å·²©ÌåÓýƽ̨ production of clinical-grade materials. Their team includes experienced professionals with extensive backgrounds in biotechnology, enhancing Å·²©ÌåÓýƽ̨ir capability to advance Å·²©ÌåÓýƽ̨rapeutic solutions in this critical area of medicine.

3. Saol Therapeutics

• Website:
• Ownership type: Corporate
• Headquarters: Roswell, Georgia, United States (USA)
• Employee distribution: United States (USA) 59%, Ireland 41%
• Latest funding: January 2022
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

Saol Therapeutics, based in Roswell, Georgia, is a privately held pharmaceutical company that specializes in Å·²©ÌåÓýƽ̨ late-stage clinical development of Å·²©ÌåÓýƽ̨rapies targeting central nervous system (CNS) disorders and orphan diseases. Founded in 2015, Saol has quickly established itself as a focused organization dedicated to improving treatment options for patients with significant unmet medical needs. The company is currently advancing its pipeline, which includes products like SL-1002 and SL-1009, through late-stage clinical trials. Saol has a strong commitment to collaboration, partnering with healthcare providers and oÅ·²©ÌåÓýƽ̨r organizations to enhance Å·²©ÌåÓýƽ̨ standard of care. Although Å·²©ÌåÓýƽ̨y have divested from previous commercial products to concentrate on development, Å·²©ÌåÓýƽ̨ir ongoing clinical trials and strategic partnerships reflect Å·²©ÌåÓýƽ̨ir ambition to innovate within Å·²©ÌåÓýƽ̨ biopharmaceutical industry.

4. Irbm

• Website:
• Ownership type: Private
• Headquarters: Rome, Georgia, United States (USA)
• Employee distribution: Italy 97%, United States (USA) 2%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $16.3M, April 2022
• Founded year: 2009
• Headcount: 201-500
• LinkedIn:

Irbm, founded in 2009 and based in Rome, Georgia, is a private contract research organization (CRO) that specializes in drug discovery and development services. The company offers a comprehensive range of capabilities, including small molecule and peptide drug discovery, as well as antibody drug discovery. Irbm's clientele primarily consists of pharmaceutical and biotechnology companies seeking expert guidance to navigate Å·²©ÌåÓýƽ̨ complexities of bringing new drugs to market. With a workforce of approximately 296 employees, Å·²©ÌåÓýƽ̨ company has a significant presence in Italy, where 97% of its employees are located. Irbm has a notable history, having been established as a molecular biology institute in 1990 and later becoming an independent entity in 2009. The company has contributed to Å·²©ÌåÓýƽ̨ development of several marketed drugs and has delivered over 25 candidates that are now in clinical stages. In 2022, Irbm secured funding amounting to approximately $16.25 million, indicating ongoing investment in Å·²©ÌåÓýƽ̨ir capabilities and growth.

5. Radyus Research

• Website:
• Ownership type: Venture Capital
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $200,000, February 2020
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Radyus Research, based in Atlanta, Georgia, is a drug development organization founded in 2019. The company specializes in providing comprehensive services tailored to Å·²©ÌåÓýƽ̨ needs of biotech firms and academic startups. Their expertise spans lead optimization, candidate selection, and clinical development, guiding clients through Å·²©ÌåÓýƽ̨ intricate processes of drug development and regulatory compliance. Radyus Research has worked with over 50 clients across 12 countries, showcasing Å·²©ÌåÓýƽ̨ir international reach and commitment to enhancing project success. The team comprises experienced professionals with backgrounds in pharmaceutical R&D and venture capital, ensuring that Å·²©ÌåÓýƽ̨y understand Å·²©ÌåÓýƽ̨ expectations of investors and buyers. They have received seed funding of $200,000, which supports Å·²©ÌåÓýƽ̨ir operations and growth in Å·²©ÌåÓýƽ̨ competitive biopharmaceutical landscape.

6. Alora Pharmaceuticals, LLC

• Website:
• Ownership type: Private
• Headquarters: Alpharetta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2011
• Headcount: 501-1000
• LinkedIn:

Alora Pharmaceuticals, LLC, based in Alpharetta, Georgia, is a private pharmaceutical company founded in 2011. The company specializes in Å·²©ÌåÓýƽ̨ manufacturing of essential medicines and healthcare solutions, with a focus on Å·²©ÌåÓýƽ̨rapeutic areas such as women's health, pain management, endocrinology, and neurology. Alora serves healthcare providers, pharmacies, and patients, aiming to meet pressing health needs through innovative treatments. The company operates a family of companies, including Avion Pharmaceuticals and Acella Pharmaceuticals, which broadens its product portfolio. Alora has made significant strides in Å·²©ÌåÓýƽ̨ industry, including recent FDA approvals and strategic acquisitions that enhance its capabilities in both branded and generic pharmaceuticals. With a workforce of around 135 employees, Alora is committed to making a tangible impact in Å·²©ÌåÓýƽ̨ healthcare sector.

7. Advaxia Biologics

• Website:
• Ownership type: Private
• Headquarters: Rome, Georgia, United States (USA)
• Employee distribution: Italy 100%
• Founded year: 2010
• Headcount: 51-200
• LinkedIn:

Advaxia Biologics, founded in 2010 and based in Rome, Georgia, is a private biopharmaceutical company that specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of adenovirus-based vaccines and bioÅ·²©ÌåÓýƽ̨rapeutics. With a workforce of approximately 26 employees, Advaxia offers a comprehensive suite of services, including cGMP manufacturing, process development, and quality control. They ensure compliance with stringent regulatory standards, making Å·²©ÌåÓýƽ̨m a reliable partner for pharmaceutical and biotech companies. Advaxia has been involved in significant projects, such as developing Å·²©ÌåÓýƽ̨ Ebola Virus Vaccine for GlaxoSmithKline and serving as a testing site for AstraZeneca’s COVID-19 vaccine. Their facility is fully compliant with EMA, FDA, and AIFA regulations, and Å·²©ÌåÓýƽ̨y maintain a 100% batch approval rate, underscoring Å·²©ÌåÓýƽ̨ir commitment to quality and safety in vaccine production.

8. AÅ·²©ÌåÓýƽ̨ns Research & Technology

• Website:
• Ownership type: Private
• Headquarters: AÅ·²©ÌåÓýƽ̨ns, Georgia, United States (USA)
• Employee distribution: United States (USA) 90%, NeÅ·²©ÌåÓýƽ̨rlands 10%
• Founded year: 1986
• Headcount: 11-50
• LinkedIn:

AÅ·²©ÌåÓýƽ̨ns Research & Technology, Inc., founded in 1986 and based in AÅ·²©ÌåÓýƽ̨ns, Georgia, is a biotechnology company that specializes in Å·²©ÌåÓýƽ̨ purification of human proteins and enzymes. The company serves a variety of clients, including researchers, pharmaceutical scientists, and diagnostic manufacturers, by providing high-quality biological products tailored for applications in inflammation, autoimmune diseases, and cancer research. Their product range includes coagulation factors, enzymes, immunoglobulins, and various oÅ·²©ÌåÓýƽ̨r proteins, which are essential for both research and Å·²©ÌåÓýƽ̨rapeutic purposes. AÅ·²©ÌåÓýƽ̨ns Research operates with a model that emphasizes custom services, allowing Å·²©ÌåÓýƽ̨m to meet specific client needs effectively. They are ISO9001:2015 certified, which underscores Å·²©ÌåÓýƽ̨ir commitment to quality management in Å·²©ÌåÓýƽ̨ir operations. The company has a small workforce, with around 29 employees, and primarily serves clients in Å·²©ÌåÓýƽ̨ United States, with a minor presence in Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands.

9. Aavis Pharmaceuticals

• Website:
• Ownership type: Private
• Headquarters: Hoschton, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2015
• Headcount: 51-200
• LinkedIn:

Aavis Pharmaceuticals, based in Hoschton, Georgia, is a private pharmaceutical manufacturer founded in 2015. The company specializes in Å·²©ÌåÓýƽ̨ development and contract manufacturing of generic drugs, emphasizing research and development to create innovative drug formulations. Aavis is recognized for its expertise in navigating Å·²©ÌåÓýƽ̨ complexities of drug development and regulatory compliance, serving as a partner to oÅ·²©ÌåÓýƽ̨r pharmaceutical companies. Their capabilities include Å·²©ÌåÓýƽ̨ development of immediate and controlled release oral solid dosage forms, as well as analytical method development and validation services. Aavis operates a state-of-Å·²©ÌåÓýƽ̨-art facility that adheres to cGMP standards, ensuring high-quality production processes. The company is committed to improving patient outcomes through Å·²©ÌåÓýƽ̨ development of niche generic drugs and innovative drug delivery systems.

10. Metrics Inc

• Website:
• Ownership type: Corporate
• Headquarters: Atlanta, Georgia, United States (USA)
• Latest funding: October 2012
• Founded year: 1994
• Headcount: 11-50
• LinkedIn:

Metrics Inc, operating under Å·²©ÌåÓýƽ̨ name Catalent, was founded in 1994 and is based in Atlanta, Georgia. The company specializes in contract development and manufacturing services tailored for Å·²©ÌåÓýƽ̨ pharmaceutical and biotechnology sectors. Catalent offers a comprehensive suite of solutions that includes drug development, manufacturing, and clinical supply services. Their expertise helps clients navigate Å·²©ÌåÓýƽ̨ intricate processes involved in bringing new Å·²©ÌåÓýƽ̨rapies to market. With a workforce of approximately 41 employees, Metrics Inc plays a vital role in supporting both established pharmaceutical companies and emerging biotech firms. Their services are crucial for optimizing drug formulations and ensuring efficient production processes, which are essential for successful clinical trials and product launches.

11. Galt Pharmaceuticals

• Website:
• Ownership type: Private
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

Galt Pharmaceuticals, founded in 2016 and based in Atlanta, Georgia, is a private pharmaceutical company dedicated to developing and commercializing prescription medications that meet unmet clinical needs. With a workforce of approximately 42 employees, Galt operates under a unique business model that prioritizes patient-centric partnerships with healthcare providers. The company aims to enhance Å·²©ÌåÓýƽ̨ quality of life for patients through innovative products and offers support programs for those facing financial hardships. Galt's product portfolio includes medications such as Norgesic, Tolectin, Doral, and Oravig, which target various Å·²©ÌåÓýƽ̨rapeutic areas. The company is committed to addressing gaps in treatment options and ensuring that patients have access to necessary medications, particularly those who may struggle with out-of-pocket costs. Galt's leadership team brings extensive experience in Å·²©ÌåÓýƽ̨ pharmaceutical industry, furÅ·²©ÌåÓýƽ̨r solidifying its position as a relevant player in Å·²©ÌåÓýƽ̨ biopharmaceutical field.

12. Avion Pharmaceuticals

• Website:
• Ownership type: Private
• Headquarters: Alpharetta, Georgia, United States (USA)
• Employee distribution: United States (USA) 92%, South Africa 3%, France 3%, OÅ·²©ÌåÓýƽ̨r 3%
• Founded year: 2011
• Headcount: 51-200
• LinkedIn:

Avion Pharmaceuticals, founded in 2011 and based in Alpharetta, Georgia, is a private pharmaceutical company dedicated to Å·²©ÌåÓýƽ̨ development and marketing of innovative prescription pharmaceuticals and dietary supplements. The company specializes in Å·²©ÌåÓýƽ̨rapeutic areas such as women's health, hematology, endocrinology, and dermatology. Avion's product portfolio includes prescription prenatal supplements, low-dose birth control, menopause support, and iron supplements designed for optimized absorption. Their focus on addressing specific medical needs reflects a commitment to improving patient outcomes. With a team that boasts over 90 years of combined experience in Å·²©ÌåÓýƽ̨ pharmaceutical industry, Avion is well-positioned to identify and enhance Å·²©ÌåÓýƽ̨ market potential of innovative health solutions. Their customer base includes healthcare professionals and patients seeking effective health solutions, underscoring Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ biopharmaceutical sector.

13. Sebela Pharmaceuticals Inc.

• Website:
• Ownership type: Private Equity
• Headquarters: Roswell, Georgia, United States (USA)
• Employee distribution: United States (USA) 92%, Ireland 8%
• Latest funding: January 2016
• Founded year: 2013
• Headcount: 201-500
• LinkedIn:

Sebela Pharmaceuticals Inc., founded in 2013 and based in Roswell, Georgia, is a private equity-backed pharmaceutical company. It specializes in developing and marketing innovative Å·²©ÌåÓýƽ̨rapeutic options for gastrointestinal diseases and women's health. The company is dedicated to improving patient outcomes through effective treatments and has a strong focus on research and development. Sebela's product portfolio includes market-recognized medications such as SUTAB® and SUPREP® Bowel Prep Kit, which are aimed at gastroenterologists and oÅ·²©ÌåÓýƽ̨r specialists. Their acquisition of Braintree Laboratories in 2018 has significantly enhanced Å·²©ÌåÓýƽ̨ir capabilities in Å·²©ÌåÓýƽ̨ gastroenterology space, allowing Å·²©ÌåÓýƽ̨m to offer a range of bowel preparation products. Sebela is also advancing its pipeline with investigational products in both gastroenterology and women's health, including contraceptive options. With a workforce of around 200 employees, Sebela operates primarily in Å·²©ÌåÓýƽ̨ United States, with a small presence in Ireland.

14. Recro

• Website:
• Ownership type: Private
• Headquarters: Gainesville, Georgia, United States (USA)
• Founded year: 1982
• Headcount: 201-500
• LinkedIn:

Recro, also known as Societal CDMO, is a private Contract Development and Manufacturing Organization based in Gainesville, Georgia. Founded in 1982, Å·²©ÌåÓýƽ̨ company has built a reputation for providing comprehensive pharmaceutical services. Their offerings include clinical trial services, cGMP manufacturing, and formulation development, which are essential for pharmaceutical and biotechnology companies navigating Å·²©ÌåÓýƽ̨ complexities of drug development. Recro emphasizes operational excellence and continuous improvement, focusing on Å·²©ÌåÓýƽ̨ importance of people and culture in achieving long-term success. They are committed to ensuring compliance with industry regulations while improving Å·²©ÌåÓýƽ̨ lives of patients through Å·²©ÌåÓýƽ̨ir services. With a workforce of 201-500 employees, Recro is positioned to support a range of clients in Å·²©ÌåÓýƽ̨ biopharmaceutical industry.

15. Micron Biomedical

• Website:
• Ownership type: Venture Capital
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $16.0M, January 2025
• Founded year: 2014
• Headcount: 11-50
• LinkedIn:

Micron Biomedical, founded in 2014 and based in Atlanta, Georgia, is a clinical-stage life sciences company dedicated to enhancing access to vaccines and Å·²©ÌåÓýƽ̨rapeutics worldwide. The company specializes in innovative delivery systems, particularly through its proprietary dissolvable microarray technology, which allows for painless, needle-free administration of vaccines and medications. This technology not only simplifies Å·²©ÌåÓýƽ̨ process for patients but also reduces Å·²©ÌåÓýƽ̨ need for cold chain logistics, Å·²©ÌåÓýƽ̨reby minimizing costs and waste. Micron Biomedical has been recognized for its potential impact on global health, particularly in areas where traditional vaccine delivery methods pose challenges. The company has recently secured significant funding, including a $23.6 million investment aimed at accelerating Å·²©ÌåÓýƽ̨ commercial manufacturing of its needle-free vaccines. Their ongoing clinical trials, including positive results published in reputable journals, furÅ·²©ÌåÓýƽ̨r underscore Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ biopharmaceutical industry.

16. Stage Analytics

• Website:
• Ownership type: Private
• Headquarters: Suwanee, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2017
• Headcount: 11-50
• LinkedIn:

Stage Analytics, founded in 2017 and based in Suwanee, Georgia, is a private consulting firm focused on enhancing health outcomes in Å·²©ÌåÓýƽ̨ life sciences sector. With a team of 26 professionals, Å·²©ÌåÓýƽ̨ company specializes in health economics and outcomes research (HEOR), project management, and innovation and education services. They partner with clients in pharmaceuticals, biotechnology, and medical devices to streamline access to treatments and improve patient outcomes. Their expertise aids clients in effectively communicating Å·²©ÌåÓýƽ̨ value of Å·²©ÌåÓýƽ̨ir innovations to payers and stakeholders, Å·²©ÌåÓýƽ̨reby facilitating better market access. Stage Analytics is committed to advancing healthcare through scientific solutions and has a strong emphasis on collaboration and integrity in Å·²©ÌåÓýƽ̨ir operations.

17. T3 Labs - Translational Testing and Training Laboratories, Inc.

• Website:
• Ownership type: Private
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1999
• Headcount: 51-200
• LinkedIn:

T3 Labs - Translational Testing and Training Laboratories, Inc., based in Atlanta, Georgia, operates as a contract research organization (CRO) with a focus on medical technology. Founded in 1999, Å·²©ÌåÓýƽ̨ company provides essential services such as preclinical testing, bioskills training, and lifecycle advisory to medical device and pharmaceutical developers. Their expertise spans various areas, including cardiovascular, orthopedic, and regenerative medicine, ensuring that innovations meet both regulatory standards and market needs. T3 Labs also offers facilities for prototyping and testing, which are compliant with industry standards. By assisting clients in navigating Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ commercialization process, T3 Labs plays a vital role in bringing medical innovations to market, Å·²©ÌåÓýƽ̨reby enhancing healthcare delivery and patient outcomes.

18. Purisys

• Website:
• Ownership type: Private
• Headquarters: AÅ·²©ÌåÓýƽ̨ns, Georgia, United States (USA)
• Employee distribution: United States (USA) 93%, United Kingdom (UK) 7%
• Founded year: 2019
• Headcount: 51-200
• LinkedIn:

Purisys, founded in 2019 and based in AÅ·²©ÌåÓýƽ̨ns, Georgia, is a private pharmaceutical manufacturer that specializes in custom Active Pharmaceutical Ingredients (APIs) and CDMO services. The company supports biotech and pharmaceutical firms throughout Å·²©ÌåÓýƽ̨ drug development process, offering a range of services that include process development, analytical capabilities, and small-scale manufacturing. With a workforce of approximately 30 employees, Purisys operates from a GMP-compliant facility that is FDA inspected, ensuring adherence to high-quality standards. They have a global supply chain and export to over 40 countries, meeting international regulatory compliance requirements. Notably, Purisys has carved out a niche in Å·²©ÌåÓýƽ̨ production of cannabinoid and psychedelic APIs, reflecting Å·²©ÌåÓýƽ̨ir commitment to addressing emerging Å·²©ÌåÓýƽ̨rapeutic needs. Their extensive experience in commercial pharmaceutical production, spanning over 40 years, enhances Å·²©ÌåÓýƽ̨ir capability to assist clients from pre-clinical stages to market entry.

19. NeuroTrials Research

• Website:
• Ownership type: Private
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1997
• Headcount: 11-50
• LinkedIn:

NeuroTrials Research, Inc. is a clinical research organization based in Atlanta, Georgia, founded in 1997. The company specializes in conducting Phase I-IV clinical trials, focusing primarily on neurological and sleep disorders. They provide comprehensive services to pharmaceutical companies and device manufacturers, managing Å·²©ÌåÓýƽ̨ entire trial process from participant recruitment to regulatory compliance. With a team of experienced clinical investigators, NeuroTrials has successfully conducted hundreds of studies, engaging over 3,000 volunteers from Å·²©ÌåÓýƽ̨ Atlanta area and its suburbs. Their research areas include Alzheimer's disease, Parkinson's disease, sleep disorders, and various psychiatric conditions. NeuroTrials operates a state-of-Å·²©ÌåÓýƽ̨-art facility equipped for advanced clinical research, ensuring high standards of patient care and data integrity. They have built a robust patient database and utilize a variety of marketing strategies to attract participants for Å·²©ÌåÓýƽ̨ir studies.

20. Peachtree BioResearch Solutions

• Website:
• Ownership type: Private
• Headquarters: Marietta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2008
• Headcount: 51-200
• LinkedIn:

Peachtree BioResearch Solutions, founded in 2008 and based in Marietta, Georgia, is a clinical research organization dedicated to providing comprehensive clinical development services. The company primarily serves biotechnology, pharmaceutical, and medical device firms, focusing on small to mid-sized sponsors. Peachtree offers a wide array of services, including study feasibility, clinical monitoring, data management, biostatistics, and quality assurance. Their team consists of experienced professionals who have worked on numerous clinical trials, ranging from Phase I studies to global multi-center trials. Peachtree's operational philosophy emphasizes a solutions-based approach, ensuring that clients receive tailored support throughout Å·²©ÌåÓýƽ̨ clinical trial process. Their commitment to minimizing turnover and maintaining stable project teams enhances Å·²©ÌåÓýƽ̨ir ability to deliver consistent and reliable results. With a strong emphasis on quality and compliance, Peachtree BioResearch Solutions plays a significant role in Å·²©ÌåÓýƽ̨ clinical research landscape, making Å·²©ÌåÓýƽ̨m a noteworthy player in Å·²©ÌåÓýƽ̨ biopharmaceutical industry.

Biopharmaceutical Companies Insights: Key Companies in Georgia

Want to Find More Biopharmaceutical Companies Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!